Candida glabrata fungemia in a tertiary cancer institution in Slovakia

Journal of Infection and Chemotherapy

Volumn 5, Issue 3, 1999, Pages 163-167

  Krcmery Jr , Vladimir ^a,b   Krupova, Iweta ^a   Mateicka, Francis ^b   Jurga, Ludovit ^b   Sulcova, Margita ^b   Spanik, Stanislav ^a   Kunová, Alena ^a   Novotny, Jozef ^b  

^a ST ELIZABETH CANCER INSTITUTE   (Slovakia)

^b TRNAVA UNIVERSITY   (Slovakia)

Author keywords

Cancer; Candida glabrata; Fungemia

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; FLUCONAZOLE; ITRACONAZOLE; VANCOMYCIN;

ARTICLE; CANCER; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FUNGEMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; RISK FACTOR; SLOVAKIA; TREATMENT OUTCOME;

EID: 13044277565     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101560050027     Document Type: Article

References (24)

1. Wingard J. Importance of Candida spp. other than C. albicans as pathogens in oncology pateints. Clin Infect Dis 1995;20:115-25.
2. Wingard J, Merz WG, Rinaldi M, Miller C, Karp J, Saral R. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother 1993;37:1847-9.
3. Kunova A, Trupl J, Krcmery V Jr. Candida glabrata and Candida krusei in 1989-1993 among fungal organisms from a single National Cancer Institute: no association with the use of fluconazole. Chemotherapy 1995;41:133-9.
4. Iwou PC, Kelly D, Reed E, Hinricks S. Invasive infection due to Candida krusei not treated with fluconazole. Clin Infect Dis 1995;20:342-5.
5. Papas PG, Rex MJ, Hamill RA, Larson WG, Powderly H, Horovitz H, et al. Current trends in nosocomial candidaemia: results of large multicenter study. Abstracts, 35th IDSA annual meeting, Sept. 13-16, 1997, San Francisco, CA, USA, abstract 13.
6. Viscoli C, ICFCG EORTC cooperative group. Fungaemia in cancer patients in Europe. Abstracts, 3rd ECCMID, Vienna, April 1-3, 1995, abstract 133.
7. Krcmery V Jr. Candidaemia in cancer patients: risk factors and outcome in 140 episodes. Acta Chemother 1997;5:133-45.
8. Clancy CJ. Correlation between in vitro susceptibility testing of Candida determined E test with microbiologic response to Amphotericin B. 35th IDSA annual meeting, Sept. 13-16, 1997, San Francisco, CA, USA, abstract 14.
9. Babincak TJ, Chan J, Tompkin NH. Clinical outcome of Candida blood stream infection based upon susceptibility testing. 35th IDSA annual meeting, Sept. 13-16, 1997, San Francisco, CA, USA, abstract 141.
10. Lee J, Peterson L, Noskin G. Correlation of antifungal susceptibility testing with clinical outcome. 35th IDSA annual meeting, Sept. 13-16, 1997, San Francisco, CA, USA, abstract 145.
11. Doongnah L, Dalaponha R, Pekers D, Reoples J, McNeil J, Frederich WR. Fungaemia in intensive care patients. 35th IDSA annual meeting. Sept. 13-16, 1997, San Francisco, CA, USA, abstract 149.
12. Jernigan JA, Nolte FS, Akkerman V, Andros A. The changing spectrum of candidaemia at a university hospital. 35th IDSA annual meeting, Sept. 13-16, 1997, San Francisco, CA, USA, abstract 661.
13. White M. Epidemiology of invasive candidiasis. Int J Infect Dis 1997;51:7-10.
14. Lecciones J, Lee LW, Navano EE, Witebsly F, Marshall D, Steinberg S, et al. Vascular catheter-associated fungaemia in patients with cancer. Clin Infect Dis 1992;14:875-83.
15. Nguyen HM, Peacock JE, Tanner DC, Moris AJ, Sugdman DR, Wadener MM, et al. Therapeutic approach in patients with candidaemia. Arch Intern Med 1995;155:2429-38.
16. Kramer DG, Bastic GP, Perri HB, Band JD. Fungaemia at a community hospital. Abstract, 34th IDSA annual meeting, Sept. 13-16, 1997, San Francisco, CA, USA, abstract 199.
17. Voss A, Noble LLMJL, Lunel VFM, Foudraino NA, Meis MGFJ. Candidaemia in intensive care unit patients. Infection 1997;25:8-15.
18. Al Soub H, Estinoso W. Hospital acquired candidaemia. J Hosp Infec 1997;35:141-7.
19. Stamous KJ, Rowley AH. Candidaemia in pediatric population. Clin Infect Dis 1995;20;571-5.
20. Roilides E, Kadiltsoglou I, Zahides D, Bibaski E. Invasive candidiasis in pediatric patients. Clin Microbiol Infect 1997;3:192-5.
21. Englund K, Noskin G, Kruszynski J, Peterson L. Yeasts on the rise. Abstracts, 34th IDSA annual meeting, New Orleans, LA, USA, abstract 341.
22. Masár O, Krčmery S, Krčmery V. Successful therapy of C. glabrata fungaemia in a pregnant women with fluconazol. J Chemother 1996;8:18-9.
23. Krcmery V Jr, Kridl J, Mardiak J, Danišovičová A. Successful therapy of fungaemia caused by Torulopsis glabrata with fluconazol. Clin Infect Dis 1994;8:1183-4.
24. Van't Wout J. Fluconazole treatment of candidat infections caused by non-albicians Candida spp. Eur J Clin Microbiol Infect Dis 1996;15:238-11.